Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James B Rose

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Regenerative Medicine|May 19, 2012
The UK relative to other single payer-dominated healthcare markets for regenerative medicine therapiesJames B Rose, David J Williams
Regenerative Medicine|March 28, 2015
Determinants of clinician adoption of regenerative therapies in the UK and Canada: an ophthalmology perspectiveJames B Rose, Michael May, David J Williams
BJU International|August 26, 2015
Budget impact of incorporating one instillation of hexaminolevulinate hydrochloride blue-light cytoscopy in transurethral bladder tumour resection for patients with non-muscle-invasive bladder cancer in SwedenJames B Rose, Shannon Armstrong, Gregers G Hermann, et al.
Journal of Functional Biomaterials|June 24, 2014
Keeping an eye on decellularized corneas: a review of methods, characterization and applicationsSamantha L Wilson, Laura E Sidney, Siobhán E Dunphy, et al.
Materials (Basel, Switzerland)|August 10, 2017
Gelatin-Based Materials in Ocular Tissue EngineeringJames B Rose, Settimio Pacelli, Alicia J El Haj, et al.
Journal of Biomedical Materials Research. Part A|December 23, 2018
In vitro evaluation of electrospun blends of gelatin and PCL for application as a partial thickness corneal graftJames B Rose, Laura E Sidney, James Patient, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Regenerative Medicine|May 19, 2012
The UK relative to other single payer-dominated healthcare markets for regenerative medicine therapiesJames B Rose, David J Williams
Regenerative Medicine|March 28, 2015
Determinants of clinician adoption of regenerative therapies in the UK and Canada: an ophthalmology perspectiveJames B Rose, Michael May, David J Williams
BJU International|August 26, 2015
Budget impact of incorporating one instillation of hexaminolevulinate hydrochloride blue-light cytoscopy in transurethral bladder tumour resection for patients with non-muscle-invasive bladder cancer in SwedenJames B Rose, Shannon Armstrong, Gregers G Hermann, et al.
Journal of Functional Biomaterials|June 24, 2014
Keeping an eye on decellularized corneas: a review of methods, characterization and applicationsSamantha L Wilson, Laura E Sidney, Siobhán E Dunphy, et al.
Materials (Basel, Switzerland)|August 10, 2017
Gelatin-Based Materials in Ocular Tissue EngineeringJames B Rose, Settimio Pacelli, Alicia J El Haj, et al.
Journal of Biomedical Materials Research. Part A|December 23, 2018
In vitro evaluation of electrospun blends of gelatin and PCL for application as a partial thickness corneal graftJames B Rose, Laura E Sidney, James Patient, et al.
Pageof 1